News
GSK Plc’s blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting its approval in doubt.
GSK today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe formulation of its ...
GSK’s attempt to relaunch Blenrep was blocked by FDA advisers due to poor clinical benefit, safety concerns, and eye-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results